2018
DOI: 10.21873/anticanres.12879
|View full text |Cite
|
Sign up to set email alerts
|

Clinicopathological Characteristics of Ovarian Metastasis from Colorectal and Pancreatobiliary Carcinomas Mimicking Primary Ovarian Mucinous Tumor

Abstract: Although the diagnosis of metastatic tumors to the ovary is possible in most cases on the basis of clinical presentation and standard diagnostic criteria, their differential diagnosis may be problematic because of morphological patterns that strikingly overlap with those of primary ovarian benign, borderline, and malignant mucinous tumors. The possibility of metastases should be considered when evaluating ovarian mucinous tumors.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
26
0
5

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 27 publications
(32 citation statements)
references
References 29 publications
1
26
0
5
Order By: Relevance
“…Overin metastatik tümörleri overyan malignensilerin %5-30'unu oluşturmaktadır (3). Metastatik müsinöz karsi- (1,2,(4)(5)(6)(7)(8)(9)(10)(11)(12). Ancak bu belirteçlerden CK7 ve CK20'nin temel olarak olguların çoğunda tanıya yardımcı olduğu bildirilmektedir.…”
Section: Discussionunclassified
See 1 more Smart Citation
“…Overin metastatik tümörleri overyan malignensilerin %5-30'unu oluşturmaktadır (3). Metastatik müsinöz karsi- (1,2,(4)(5)(6)(7)(8)(9)(10)(11)(12). Ancak bu belirteçlerden CK7 ve CK20'nin temel olarak olguların çoğunda tanıya yardımcı olduğu bildirilmektedir.…”
Section: Discussionunclassified
“…İmmünohistokimyasal olarak olgulara uygulanan CK7 ve CK20 ile değerlendirme yapıldığında; primer tümörlerin tamamında CK7 (+) / CK20 (-) idi. CK7 (+) / CK20 (-) olan olgulardan iki tanesi daha önce tanı almış meme karsinomu, bir tanesi de endometrial mikst karsinom GIRIŞ Pankreas, apendiks, meme, kolon, mide ve jinekolojik organlar başta olmak üzere pek çok organın overe metastaz yaptığı bilinmektedir (1,2). Çoğu zaman primer tümör önceden bilinse de bazen hasta ilk bulgu olarak pelvik kitle ile başvurabilmektedir.…”
Section: Bulgularunclassified
“…The 4 µm-thick, FFPE slices were de-paraffinized and rehydrated using a xylene and alcohol solution. Immunostaining was performed using automated instruments (Ventana Benchmark XT (Ventana Medical Systems) and or Dako Omnis (Dako, Carpinteria, CA, USA)) [1,[18][19][20][21][22][23][24][25][26]. After antigen retrieval, the slices were incubated with primary antibodies including pan-cytokeratin (pan-CK; 1:600, clone AE1/AE3, Dako), CK7 (Dako, 1:100, clone OV-TL 12/30, Dako), CK20 (1:100, clone Ks20.8, Dako), caudal type homeobox 2 (CDX2; 1:400, clone EPR2764Y, Cell Marque, Rocklin, CA, USA), paired box 8 (PAX8; 1:50, polyclonal, Cell Marque), estrogen receptor (ER; 1:150, clone 6F11, Novocastra, Leica Biosystems, Newcastle Upon Tyne, UK), progesterone receptor (PR; 1:100, clone 16, Novocastra), p53 (1:300, clone DO-7, Novocastra), p16 (prediluted, clone E6H4, Ventana Medical Systems), p63 (1:50, clone 4A4, Dako), and GATA-binding protein 3 (GATA3; 1:150, clone L50-823, Cell Marque).…”
Section: Immunohistochemistrymentioning
confidence: 99%
“…Metastases to female reproductive organs often pose diagnostic challenges for both pathologists and clinicians, and tend to be overlooked in the differential diagnoses of other gynecological malignancies. In the rare event of metastases to the female genital tract, the ovaries are most often affected [1]. Malignancies that secondarily involve the uterus usually extend directly from adjacent pelvic organs including the rectum, urinary bladder, and peritoneum; alternatively, they may develop consequent to widespread peritoneal dissemination.…”
Section: Introductionmentioning
confidence: 99%
“…Systems)] according to the manufacturer's recommendations (9,(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35). Antigen retrieval was performed using Cell Conditioning Solution (CC1, Ventana Medical Systems).…”
Section: Immunohistochemical Staining Immunostaining Was Performed Umentioning
confidence: 99%